ADVERTISEMENT — Advertise With Biotech Networks
No Picture
Industry News

Novo helps birth startup advancing an AstraZeneca castoff with $15M; Japan’s Fuji Pharma wagers $50M on Alvotech’s biosimilars

? With backing from Novo Holdings and a drug from AstraZeneca, Aristea Therapeutics is unveiling a $15 million Series A that will kickstart Phase II studies of its lead program, RIST4721. James Mackay, who used to run AstraZeneca-acquired Ardea Bioscie… […]


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
Industry News

Harvard prof Omid Farokhzad heads west, setting up a new Bay Area biotech on a mission to start a revolution in pre-symptomatic disease detection

As a Harvard professor with close ties to MIT?s Bob Langer, Omid Farokhzad has enjoyed a high-profile role in the Boston/Cambridge biotech community, where he?s participated in launching a lineup of startups. And now Farokhzad ? whose accomplishments e… […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
Industry News

Data Science Freshman Makes His First Cloud

Since coding is fun to freshman Yuan Gao, creating his first word cloud from the Facebook page of Hal?c?o?lu Data Science Institute at UC San Diego was basically entertainment. He created the montage-style graph… […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
Industry News

Lilly, Incyte’s baricitinib wins fast-track status for hard-to-treat lupus; Synthorx hammers out $150M+ IPO

? Rheumatoid arthritis drug Olumiant?? approved for a narrower-than-expected patient population earlier this year to the dismay of its manufacturer Eli?Lilly $LLY and Incyte $INCY which had blockbuster dreams for the drug?? may be worth its weight in g… […]

No Picture
Industry News

Lilly, Incyte’s baricitinib wins fast-track status for hard-to-treat lupus; Synthorx hammers out $150M+ IPO

? Rheumatoid arthritis drug Olumiant?? approved for a narrower-than-expected patient population earlier this year to the dismay of its manufacturer Eli?Lilly $LLY and Incyte $INCY which had blockbuster dreams for the drug?? may be worth its weight in g… […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
Industry News

Biotech Briefing: Local Biotech Venture Capital Update

Reports + Research Local Biotech Venture Capital Update DealForma catalogues the largest local venture capital sources, including number and total of venture rounds.? Leading the pack for number of venture rounds are Avalon Ventures and Correlation Ven… […]

No Picture
Industry News

Biotech Briefing: Local Biotech Venture Capital Update

Reports + Research Local Biotech Venture Capital Update DealForma catalogues the largest local venture capital sources, including number and total of venture rounds.? Leading the pack for number of venture rounds are Avalon Ventures and Correlation Ven… […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
Industry News

WuXi AppTec cruises toward a steady debut in Hong Kong stock exchange, ending flat on IPO price

Completing a grand plan for a dual listing in Shanghai and Hong Kong in the span of seven months, WuXi AppTec has debuted on the HKEX, ending the day at its original IPO price.
Net proceeds will register at $967 million (HK $7,553 million), the company… […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
Industry News

Early Surveillance with L-Dex® Reduces Incidence, Severity & Cost of Breast Cancer-Related Lymphedema, ImpediMed Reports Publication in American Cancer Society Journal

BRISBANE, Australia & CARLSBAD, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Lymphedema?src=hash" target="_blank"gt;#Lymphedemalt;/agt;–L-Dex Reduces Incidence, Severity & Cost of Breast Cancer-Related Ly… […]

No Picture
Industry News

Apexian Pharmaceuticals Presents Findings at ASH Meeting Demonstrating APX3330 Impact on Inflammation and Leukemia?in Preclinical Models

INDIANAPOLIS–(BUSINESS WIRE)–Apexian Pharmaceuticals is shedding light on the question of how pre-leukemic cells transform into full-blown leukemia. Genetic mutations by themselves are rarely enough to flip the switch. Inflammation also plays a role…. […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
Industry News

Pfizer adds 100 to cancer research center in La Jolla

Pfizer is adding 100 jobs to its oncology research center in La Jolla, increasing employment to more than 900. Pfizer is transferring those positions from its site in South San Francisco. The move, announced Monday, was made to simplify the structu… […]